NCT06565715View on ClinicalTrials.gov

Effect of Remazolam on Hemodynamics During Hepatectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 23, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

November 8, 2024

Conditions
Hemodynamic Instability
Interventions
DRUG

Remimazolam

Remimazolam is used for sedation during anesthetic induction and maintenance.

DRUG

Propofol

propofol is used for sedation during anesthetic induction and maintenance.

Trial Locations (1)

Unknown

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Jun Zhang

OTHER

NCT06565715 - Effect of Remazolam on Hemodynamics During Hepatectomy | Biotech Hunter | Biotech Hunter